OBJECTIVE: We prospectively evaluated the feasibility and technical features of MR-guided lumbosacral injection procedures in open high-field MRI at 1.0 T. METHODS: In a CuSO(4).5H(2)O phantom and five human cadaveric spines, fluoroscopy sequences (proton-density-weighted turbo spin-echo (PDw TSE), T1w TSE, T2w TSE; balanced steady-state free precession (bSSFP), T1w gradient echo (GE), T2w GE) were evaluated using two MRI-compatible 20-G Chiba-type needles. Artefacts were analysed by varying needle orientation to B(0), frequency-encoding direction and slice orientation. Image quality was described using the contrast-to-noise ratio (CNR). Subsequently, a total of 183 MR-guided nerve root (107), facet (53) and sacroiliac joint (23) injections were performed in 53 patients. RESULTS: In vitro, PDw TSE sequence yielded the best needle-tissue contrasts (CNR = 45, 18, 15, 9, and 8 for needle vs. fat, muscle, root, bone and sclerosis, respectively) and optimal artefact sizes (width and tip shift less than 5 mm). In vivo, PDw TSE sequence was sufficient in all cases. The acquisition time of 2 s facilitated near-real-time MRI guidance. Drug delivery was technically successful in 100% (107/107), 87% (46/53) and 87% (20/23) of nerve root, facet and sacroiliac joint injections, respectively. No major complications occurred. The mean procedure time was 29 min (range 19-67 min). CONCLUSION: MR-guided spinal injections in open high-field MRI are feasible and accurate using fast TSE sequence designs.
OBJECTIVE: We prospectively evaluated the feasibility and technical features of MR-guided lumbosacral injection procedures in open high-field MRI at 1.0 T. METHODS: In a CuSO(4).5H(2)O phantom and five human cadaveric spines, fluoroscopy sequences (proton-density-weighted turbo spin-echo (PDw TSE), T1w TSE, T2w TSE; balanced steady-state free precession (bSSFP), T1w gradient echo (GE), T2w GE) were evaluated using two MRI-compatible 20-G Chiba-type needles. Artefacts were analysed by varying needle orientation to B(0), frequency-encoding direction and slice orientation. Image quality was described using the contrast-to-noise ratio (CNR). Subsequently, a total of 183 MR-guided nerve root (107), facet (53) and sacroiliac joint (23) injections were performed in 53 patients. RESULTS: In vitro, PDw TSE sequence yielded the best needle-tissue contrasts (CNR = 45, 18, 15, 9, and 8 for needle vs. fat, muscle, root, bone and sclerosis, respectively) and optimal artefact sizes (width and tip shift less than 5 mm). In vivo, PDw TSE sequence was sufficient in all cases. The acquisition time of 2 s facilitated near-real-time MRI guidance. Drug delivery was technically successful in 100% (107/107), 87% (46/53) and 87% (20/23) of nerve root, facet and sacroiliac joint injections, respectively. No major complications occurred. The mean procedure time was 29 min (range 19-67 min). CONCLUSION: MR-guided spinal injections in open high-field MRI are feasible and accurate using fast TSE sequence designs.
Authors: Jan Fritz; Jörg C Henes; Christoph Thomas; Stephan Clasen; Michael Fenchel; Claus D Claussen; Jonathan S Lewin; Philippe L Pereira Journal: AJR Am J Roentgenol Date: 2008-12 Impact factor: 3.959
Authors: Patrick Freyhardt; Tony Hartwig; Maximilian De Bucourt; Martin Maurer; Diane Renz; Bernhard Gebauer; Bernd Hamm; Ulf K M Teichgräber; Florian Streitparth Journal: Eur Radiol Date: 2013-06-28 Impact factor: 5.315
Authors: Florian Streitparth; Tony Hartwig; Thula Walter; Maximilian De Bucourt; Michael Putzier; Patrick Strube; Tina Bretschneider; Patrick Freyhardt; Martin Maurer; Diane Renz; Bernhard Gebauer; Bernd Hamm; Ulf K M Teichgräber Journal: Eur Radiol Date: 2013-05-09 Impact factor: 5.315
Authors: Jens Christian Rump; Martin Jonczyk; Christian Jürgen Seebauer; Florian Streitparth; Felix Victor Güttler; Ulf Karl-Martin Teichgräber; Bernd Hamm Journal: Int J Comput Assist Radiol Surg Date: 2011-03-17 Impact factor: 2.924
Authors: M Porsch; J J Wendler; F Fischbach; D Schindele; A Janitzky; D Baumunk; U-B Liehr; J Ricke; M Schostak Journal: Urologe A Date: 2012-12 Impact factor: 0.639
Authors: Florian Streitparth; T Hartwig; B Schnackenburg; P Strube; M Putzier; S Chopra; M De Bucourt; B Hamm; U Teichgräber Journal: Eur Radiol Date: 2010-11-30 Impact factor: 5.315
Authors: M H Maurer; N Schreiter; M de Bucourt; C Grieser; D M Renz; T Hartwig; B Hamm; F Streitparth Journal: Eur Radiol Date: 2013-01-12 Impact factor: 5.315